Sandra Vidal-Lletjós1, Nadezda V Khodorova1, Maria Piscuc1, Claire Gaudichon1, François Blachier1, Annaïg Lan2. 1. Université Paris-Saclay, AgroParisTech, INRAE, UMR PNCA, Equipe Apports protéiques et Adaptations Intestinales, 16 rue Claude Bernard, 75005, Paris, France. 2. Université Paris-Saclay, AgroParisTech, INRAE, UMR PNCA, Equipe Apports protéiques et Adaptations Intestinales, 16 rue Claude Bernard, 75005, Paris, France. annaig.lan@agroparistech.fr.
Abstract
PURPOSE: Inflammatory bowel diseases are associated with an increase in the whole-body protein turnover, thus possibly requiring an additional supply of dietary proteins. Our aim was to evaluate whether increasing dietary protein content could alleviate protein metabolism alterations in the injured splanchnic and peripheral tissues during colitis and spontaneous mucosal healing. METHODS: Mice with acute chemically induced colitis received either a normal protein (P14, 14% as energy), a moderately (P30, 30%) and a very high-protein (P53, 55%) diets. At different times after the challenge, protein synthesis rate was determined in tissues using a flooding dose of 13C valine. RESULTS: Colon, liver and spleen protein synthesis rates were significantly increased after colitis induction, while being decreased in the caecum, kidneys and muscle. Contrastingly to the two other diets, P30 diet consumption allowed faster recovery of the animals, and this coincided with a rapid resaturation of the initial protein synthesis in the colon. In the other tissues studied, the high-protein diets show different effects depending on the dietary protein content consumed and on the examined tissues, with a general trend of P53 in lowering anabolism rates. CONCLUSION: This study highlights the severe impact of acute colonic inflammation on protein metabolism in different organs. In addition, dietary protein content modulated the recovery of the initial protein synthesis rate in the various tissues following colitis induction. P30 diet consumption notably showed a better ability to alleviate protein metabolism perturbations induced by colitis, that may explain its documented beneficial effect on colon mucosal healing.
PURPOSE:Inflammatory bowel diseases are associated with an increase in the whole-body protein turnover, thus possibly requiring an additional supply of dietary proteins. Our aim was to evaluate whether increasing dietary protein content could alleviate protein metabolism alterations in the injured splanchnic and peripheral tissues during colitis and spontaneous mucosal healing. METHODS:Mice with acute chemically induced colitis received either a normal protein (P14, 14% as energy), a moderately (P30, 30%) and a very high-protein (P53, 55%) diets. At different times after the challenge, protein synthesis rate was determined in tissues using a flooding dose of 13C valine. RESULTS: Colon, liver and spleen protein synthesis rates were significantly increased after colitis induction, while being decreased in the caecum, kidneys and muscle. Contrastingly to the two other diets, P30 diet consumption allowed faster recovery of the animals, and this coincided with a rapid resaturation of the initial protein synthesis in the colon. In the other tissues studied, the high-protein diets show different effects depending on the dietary protein content consumed and on the examined tissues, with a general trend of P53 in lowering anabolism rates. CONCLUSION: This study highlights the severe impact of acute colonic inflammation on protein metabolism in different organs. In addition, dietary protein content modulated the recovery of the initial protein synthesis rate in the various tissues following colitis induction. P30 diet consumption notably showed a better ability to alleviate protein metabolism perturbations induced by colitis, that may explain its documented beneficial effect on colon mucosal healing.
Entities:
Keywords:
Colon inflammation; High-protein diet; Mucosal healing; Protein metabolism
Authors: Annaïg Lan; Anne Blais; Desire Coelho; Juliette Capron; Manar Maarouf; Robert Benamouzig; Antonio H Lancha; Francine Walker; Daniel Tomé; François Blachier Journal: Am J Physiol Gastrointest Liver Physiol Date: 2016-08-25 Impact factor: 4.052
Authors: Andres J Yarur; Maria A Quintero; Anjali Jain; Frank Czul; Jamie S Barkin; Maria T Abreu Journal: Inflamm Bowel Dis Date: 2017-01 Impact factor: 5.325
Authors: Stephan R Vavricka; Alain Schoepfer; Michael Scharl; Peter L Lakatos; Alexander Navarini; Gerhard Rogler Journal: Inflamm Bowel Dis Date: 2015-08 Impact factor: 5.325
Authors: F Scaldaferri; M Pizzoferrato; L R Lopetuso; T Musca; F Ingravalle; L L Sicignano; M Mentella; G Miggiano; M C Mele; E Gaetani; C Graziani; V Petito; G Cammarota; E Marzetti; A Martone; F Landi; A Gasbarrini Journal: Gastroenterol Res Pract Date: 2017-01-03 Impact factor: 2.260